Hi Igor
Welcome to the forum.
Jeff is correct – it will depend on whether the condition will impose a significant cost to the Australian taxpayer or whether it will lead to an Australian being deprived of scare resources.
Have a read of
this post for further information on the health requirement. In particular please note what constitutes a ‘significant cost’ and ‘resource use impact’.
My understanding of chronic glomerulonephritis is that it is a kidney disorder which
can lead to end-chronic kidney failure requiring dialysis or kidney transplantation. But I also understand that treatment varies depending on the cause of the disorder, and the type and severity of symptoms, and that some types of glomerulonephritis may get better on their own.
Without knowing any more about his condition I would counsel you that it is likely to be an uphill battle. Having said that, if he is determined to apply for the visa, he should seriously consider engaging a migration agent who has experience in handling serious health conditions of this nature. This will ensure he gets the best advice and assistance and will optimise his chances if the agent feels there is any likelihood of success.
To give you some idea of the likely costs involved in Australia here is an extract from an MRT decision made in 2003 for an applicant with chronic glomerulonephritis. The Medical Officer of the Commonweatlh (MOC) found that:
“if the visa applicant were to be granted the visa he would require significant care or treatment (or both) and it would result in the visa applicant becoming a significant charge on public funds. The MOC's decision was due to the visa applicant having evidence of chronic glomerulonephritis which has resulted in significant renal damage, this was discovered during the routine immigration health check.
The MOC stated that while the visa applicant will not require intensive therapy or dialysis in the near future he is likely to progress to end stage renal failure and renal dialysis in 10-15 years. The cost for treatment is likely to be $1000-$2000 per annum for the next 5-10 years, this will increase to $30 000 per annum after 10-15 years. If the visa applicant requires renal transplantation this will cost approximately $50 000 and approximately $10 000 per annum thereafter.
The likely costs to the Australian community in the area of health and community services would be as follows:
- Regular specialist review with pathology testing to monitor renal function, $1000 pa;
- Drug therapy such as erythripoietin for anaemia, and for treatment of metabolic bone disease and hypertension, $9000 - $12 000 pa;
- Renal support therapy (dialysis) which will be required within 6 months, $27 000 - $37 000 pa;
- Income support which is likely to be required once he begins dialysis $10 000 pa.
The likely lifetime cost for this applicant, to the age of 60 years, is therefore estimated to be within the range of $709 000 to $900 000 - a significant cost indeed.
Diseases and their influence on migration process
Linear Mode
